Kymera Therapeutics (KYMR) Earnings (2019 - 2026)
Kymera Therapeutics (KYMR) earnings from Sep 30, 2019 to Mar 31, 2026. The TTM Kymera Therapeutics (KYMR) earnings is -$315M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Kymera Therapeutics (KYMR) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +30.77% |
| 3 Years TTM | +25.58% |
| 5 Years TTM | +45.84% |
| All Time TTM | +50.81% |
Annual Earnings change of Kymera Therapeutics (KYMR)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$69M | -77.76% |
| 2025 | -$311M | +39.08% |
| 2024 | -$224M | +52.33% |
| 2023 | -$147M | -5.07% |
| 2022 | -$155M | +54.47% |
| 2021 | -$100M | +119.83% |
| 2020 | -$46M | +10.52% |
| 2019 | -$41M | N/A |
Comparison Kymera Therapeutics (KYMR) five years earnings CAGR with competitors
Kymera Therapeutics (KYMR) five years earnings CAGR is 45.85%.